Dr Abhijit Pal specialises in Phase 1 cancer trials and thoracic malignancies. He completed a Phase 1 trials fellowship at the Drug Development Unit, Royal Marsden Hospital in London from 2019 – 2020. He was awarded a PhD in 2023 through the University of Sydney (supervised by Professor Frances Boyle), looking at informed consent for Phase 1 trials and ways to improve the representation of patients from culturally and linguistically diverse backgrounds on to cancer clinical trials.